ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 92 filers reported holding ORIC PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 6.67 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,949,774 | -34.6% | 3,132,194 | -16.1% | 0.00% | 0.0% |
| Q2 2023 | $28,962,244 | -36.6% | 3,732,248 | -53.4% | 0.00% | 0.0% |
| Q1 2023 | $45,680,930 | +93.1% | 8,014,198 | +99.5% | 0.00% | 0.0% |
| Q4 2022 | $23,657,822 | +70.0% | 4,016,608 | -7.6% | 0.00% | +100.0% |
| Q3 2022 | $13,915,000 | -28.7% | 4,348,392 | -0.2% | 0.00% | -50.0% |
| Q2 2022 | $19,512,000 | -17.3% | 4,355,182 | -1.4% | 0.00% | 0.0% |
| Q1 2022 | $23,594,000 | -72.8% | 4,418,413 | -25.2% | 0.00% | -66.7% |
| Q4 2021 | $86,837,000 | -29.6% | 5,907,279 | +0.2% | 0.01% | -40.0% |
| Q3 2021 | $123,320,000 | +26.6% | 5,897,652 | +7.1% | 0.01% | +25.0% |
| Q2 2021 | $97,372,000 | -27.8% | 5,504,372 | +0.0% | 0.01% | -33.3% |
| Q1 2021 | $134,854,000 | -26.9% | 5,504,252 | +1.0% | 0.01% | -25.0% |
| Q4 2020 | $184,562,000 | +65.9% | 5,452,347 | +21.3% | 0.02% | +45.5% |
| Q3 2020 | $111,226,000 | -19.9% | 4,493,328 | +6.8% | 0.01% | -26.7% |
| Q2 2020 | $138,794,000 | – | 4,206,948 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 602,272 | $2,698,000 | 8.92% |
| Column Group LLC | 3,568,181 | $15,985,000 | 3.40% |
| Euclidean Capital LLC | 747,550 | $3,349,000 | 2.85% |
| Invus Financial Advisors, LLC | 1,007,575 | $4,514,000 | 2.72% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,082,304 | $4,849,000 | 1.49% |
| Monaco Asset Management SAM | 364,741 | $1,634,000 | 0.71% |
| EcoR1 Capital, LLC | 3,418,068 | $15,313,000 | 0.53% |
| DAFNA Capital Management LLC | 415,926 | $1,863,000 | 0.51% |
| Boxer Capital, LLC | 1,054,000 | $4,722,000 | 0.30% |
| Casdin Capital, LLC | 601,515 | $2,695,000 | 0.23% |